Cis-monounsaturated fatty acids inhibit ferroptosis through downregulation of transferrin receptor 1

Ferroptosis, a form of cell death mediated by lipid peroxidation, is implicated in various pathological processes. Although monounsaturated fatty acids (MUFAs) can inhibit ferroptotic lipid peroxidation, the underlying structural mechanism of this antagonistic effect remains poorly understood. We hypothesized that MUFAs with different structures (including chain length, conformation, and double bond position) may affect their regulatory effect on ferroptosis. In this study, 11 MUFAs with varying structures were screened to identify those with an inhibitory effect on ferroptosis. Results from 3-(4, 5-dimethylthiazol-2-yl)2, 5-diphenyltetrazoliumbromide assays indicated that only exogenous MUFAs with cisconformation and centered double bond could inhibit ferroptosis. Meanwhile, it was found that suppressing the expression of SCD1 and SCD5 genes could sensitize cells to ferroptosis indicating the protective role of endogenous MUFA against ferroptosis. Additionally, western blot analysis revealed that cis-MUFAs with centered double bond downregulated the protein levels of transferrin receptor 1. Flow cytometry confirmed that these MUFAs led to decreases in intracellular iron, reactive oxygen species, and lipid peroxides. It was also found that SCD1 inhibitor could enhance ferroptosis inducer-mediated tumor suppression both in vivo and in vitro . Overall, these findings shed light on the particular structural features of MUFAs that contribute to their ferroptosis-resistant properties and suggest the potential therapeutic relevance of natural MUFAs in a range of ferroptosis-related diseases. & COPY; 2023 Published by Elsevier Inc.

Automated summary

This study found that MUFAs with specific structural features, such as cis-conformation and centered double bond, can inhibit ferroptosis. Inhibition of SCD1 and SCD5 genes sensitizes cells to ferroptosis, suggesting the protective role of endogenous MUFA. These findings provide insights into the potential therapeutic applications of MUFAs in ferroptosis-related diseases.